Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

Details for Australian Patent Application No. 2010216219 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Aronov, Alex; Bandarage, Upul Keerthi; Cottrell, Kevin; Davies, Robert; Krueger, Elaine; Ledeboer, Mark; Ledford, Brian; Le Tiran, Arnaud; Liao, Yusheng; Messersmith, David; Wang, Tiansheng; Xu, Jinwang

Agent Baldwins

Pub. Number AU-A-2010216219

PCT Pub. Number WO2010/096389

Priority 61/153,056 17.02.09 US

Filing date 16 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/4365 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/096389 Priority application(s): WO2010/096389

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010216223-Memory architecture with a current controller and reduced power requirements

2010216210-Treatment of a pelvic condition through indirect electrical stimulation